Evidence map›Paper›PMID 7539043›Full record

ArticleThe Journal of experimental medicine1995

Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.

K W Muszynski, F W Ruscetti, G Heidecker, U Rapp, J Troppmair, J M Gooya, J R Keller

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1998
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

K W MuszynskiBiological Carcinogenesis and Development Program, Program Resources Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
F W Ruscetti
G Heidecker
U Rapp
J Troppmair
J M Gooya
J R Keller
LabCorp (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raf-1 is a 74-kD serine/threonine kinase located in the cell cytoplasm that is activated by phosphorylation in cells stimulated with a variety of mitogens and growth factors, including hematopoietic growth factors. Using c-raf antisense oligonucleotides to block Raf-1 expression, we have established that Raf-1 is required for hematopoietic growth factor-induced proliferation of murine cell lines stimulated by growth factors whose receptors are members of several different structural classes: (a) the hematopoietin receptor family, including interleukin (IL)-2, IL-3, IL-4, granulocyte colony-stimulating factor, granulocyte/macrophage colony-stimulating factor (GM-CSF), and erythropoietin; (b) the tyrosine kinase receptor class, including Steel factor and CSF-1; and (c) IL-6, leukemia inhibitory factor, and oncostatin M, whose receptors include the gp130 receptor subunit. Although results of previous experiments had suggested that IL-4 does not phosphorylate or activate the Raf-1 kinase, c-raf antisense oligonucleotides inhibited IL-4-induced proliferation of both myeloid and T cell lines, and IL-4 activated Raf-1 kinase activity in an IL-4-dependent myeloid cell line. In colony assays, c-raf antisense oligonucleotides completely inhibited colony formation of unseparated normal murine bone marrow cells stimulated with either IL-3 or CSF-1 and partially inhibited cells stimulated with GM-CSF. In addition, c-raf antisense oligonucleotides completely inhibited both IL-3- and GM-CSF-induced colony formation of CD34+ purified human progenitors stimulated with these same growth factors. Thus, Raf-1 is required for growth factor-induced proliferation of leukemic murine progenitor cell lines and normal murine and human bone marrow-derived progenitor cells regardless of the growth factor used to stimulate cell growth.

Indexed as

Interleukin-6AnimalsBase SequenceBone Marrow CellsCell DivisionCell LineDNAErythropoietinGene ExpressionGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorGrowth InhibitorsGrowth SubstancesHematopoietic Cell Growth FactorsHematopoietic Stem CellsInterleukinsDNAErythropoietinGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorGrowth InhibitorsGrowth SubstancesHematopoietic Cell Growth FactorsInterleukin-6InterleukinsLeukemia Inhibitory FactorLIF protein, humanLif protein, mouseLymphokinesMacrophage Colony-Stimulating FactorOligonucleotides, AntisenseOncostatin MOSM protein, humanOsm protein, mousePeptidesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-rafStem Cell Factor

Identifiers

PMID7539043
PMCPMC2192061
OpenAlexW2159466824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.